Biochrom, Gilson Sign ELISA Distribution Agreement
News Jun 10, 2014
The partnership combines the strength of the EZ Read range of microplate readers from Biochrom, with Gilson’s innovative line of liquid handling systems. Used together the flexible offering enables scientists to easily automate their absorbance assays including ELISA, total protein and cell viability.
Biochrom created the EZ Read microplate reader range by matching its expertise in absorbance measurement with requests from scientists and technicians to make their experimental workflow easier and more effective. Gilson has incorporated its vast knowledge of liquid transfer techniques into a wide range of automated liquid handlers.
Tristana von Will, Global Product Marketing Manager at Biochrom, commented: “Gilson is a leader in liquid handling systems and we are delighted to be combining the heritage and expertise of both companies to co-sell our product ranges. Researchers and technicians will be very familiar with both the Biochrom and Gilson brands, but together we can further streamline experimental workflows for our customers.”
Ronan Herry, European Marketing Director at Gilson International BV, stated:” The Biochrom range of EZ Read Microplate readers fits very well with our range of liquid handling products, either for those customers who require manual or electronic multichannel pipettes from the PIPETMAN range or for those customers that would like to automate their lab work flows. The Gilson PIPETMAX comes at a size and price that is accessible to any lab and takes away the stress and strain of manual pipetting for ELISA and Bradford type assays while improving reproducibility. Adding the Biochrom range now enables Gilson to offer a complete applications solution for our customers”.
Being Born During a Flu Pandemic May Increase Your Risk of Death During Another Flu PandemicNews
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, researchers are calling for more attention to exceptions to that rule.READ MORE
Glythera Appoints Chief Scientific Officer and Strengthens SABNews
Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.READ MORE
Stainless Steel That Is More Resistant to BacteriaNews
Stainless steel is widely used in surgical instruments and implants but over time, implants can be rejected by the body and in unhygienic surgical environments, steel may not adequately resist the accumulation of harmful bacteria. However, scientists have now developed a way to modify the surface of the stainless steel by creating a set of pores at the nanoscale. The improved material could benefit the food and beverage industry as well as medicine.READ MORE